Blog

Oct 28, 2024, 10:54

SPCC – Brian Druker reflects on the key milestones of his life and career

SPCC (Sharing Progress in Cancer Care) shared on Linkedin:

”Have you already watched Aleksandra Filipovic’s inspirational interview with Brian Druker, the esteemed director of the OHSU Knight Cancer Institute?

Known for his groundbreaking work in cancer research, Druker developed Gleevec, a targeted therapy that revolutionised the treatment of chronic myeloid leukemia (CML) by attacking cancer cells while preserving healthy ones.

In the interview, Druker reflects on the key milestones of his life and career, from his early days to his present work.

Every new drug has a human who has championed it to existence, who persevered, who believed. Who knew the ‘Why’ and therefore found the ‘How’.

Watch it now.”

Aleksandra Filipovic Brian Druker cancer Cancer research Chronic myeloid leukemia (CML) CML OHSU Knight Cancer Institute OncoDaily Oncology SPCC (Sharing Progress in Cancer Care)

Oncologist Near Me - Vivek Subbiah: Pionner of Precision Oncology

Monica Bertagnolli is ending her tenure as NIH director

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

Special Coverage